These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29384977)

  • 21. Myocyte damage and loss of myofibers is the potential mechanism of iron overload toxicity in congestive cardiac failure in thalassemia. Complete reversal of the cardiomyopathy and normalization of iron load by deferiprone.
    Kolnagou A; Michaelides Y; Kontos C; Kyriacou K; Kontoghiorghes GJ
    Hemoglobin; 2008; 32(1-2):17-28. PubMed ID: 18274979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation from a deceased donor with β-thalassemia intermedia is not contraindicated: A case report.
    Gumus E; Abbasoglu O; Tanyel C; Gumruk F; Ozen H; Yuce A
    Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28211259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined iron chelation therapy.
    Galanello R; Agus A; Campus S; Danjou F; Giardina PJ; Grady RW
    Ann N Y Acad Sci; 2010 Aug; 1202():79-86. PubMed ID: 20712777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term administration of high-dose deferoxamine 2 days per week in thalassemic patients.
    Hagège I; Becker A; Kerdaffrec T; Kanfer A; Girot R
    Eur J Haematol; 2001 Oct; 67(4):230-1. PubMed ID: 11860443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deferasirox for managing transfusional iron overload in people with sickle cell disease.
    Meerpohl JJ; Antes G; Rücker G; Fleeman N; Niemeyer C; Bassler D
    Cochrane Database Syst Rev; 2010 Aug; (8):CD007477. PubMed ID: 20687088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications.
    Chuang TY; Li JP; Weng TF; Wu KH; Chao YH
    Ann Hematol; 2020 Oct; 99(10):2289-2294. PubMed ID: 32737633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*.
    Kolnagou A; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2006; 30(2):219-27. PubMed ID: 16798647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined chelation therapy in thalassemia major with deferiprone and desferrioxamine: a retrospective study.
    Ricchi P; Ammirabile M; Spasiano A; Costantini S; Cinque P; Di Matola T; Pagano L; Prossomariti L
    Eur J Haematol; 2010 Jul; 85(1):36-42. PubMed ID: 20331740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urine biochemical markers of early renal dysfunction are associated with iron overload in beta-thalassaemia.
    Koliakos G; Papachristou F; Koussi A; Perifanis V; Tsatra I; Souliou E; Athanasiou M
    Clin Lab Haematol; 2003 Apr; 25(2):105-9. PubMed ID: 12641614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron chelation with deferoxamine: comparing the results of a critical pathway to a national survey.
    DeSwarte-Wallace J; Groncy PK; Finklestein JZ
    J Pediatr Hematol Oncol; 1999; 21(2):136-41. PubMed ID: 10206460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety monitoring of cardiac and hepatic systems in beta-thalassemia patients with chelating treatment in Taiwan.
    Peng CT; Chow KC; Chen JH; Chiang YP; Lin TY; Tsai CH
    Eur J Haematol; 2003 Jun; 70(6):392-7. PubMed ID: 12756022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children's Hospital experience.
    Abdelrazik N
    Hematology; 2007 Dec; 12(6):577-85. PubMed ID: 17852442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron overload in a teenager with xerocytosis: the importance of nuclear magnetic resonance imaging.
    Assis RA; Kassab C; Seguro FS; Costa FF; Silveira PA; Wood J; Hamerschlak N
    Einstein (Sao Paulo); 2013 Dec; 11(4):528-32. PubMed ID: 24488397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging.
    Wahidiyat PA; Liauw F; Sekarsari D; Putriasih SA; Berdoukas V; Pennell DJ
    Hematology; 2017 Sep; 22(8):501-507. PubMed ID: 28218005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes.
    Kontoghiorghe CN; Kontoghiorghes GJ
    Drug Des Devel Ther; 2016; 10():465-81. PubMed ID: 26893541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intensive intravenous chelation in thalassemic patients with iron overload].
    Di Gregorio F; Leonardi C; Sciuto C; Cannella A; Pizzarelli G
    Minerva Pediatr; 1998 Mar; 50(3):81-5. PubMed ID: 9676102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*.
    Kolnagou A; Natsiopoulos K; Kleanthous M; Ioannou A; Kontoghiorghes GJ
    Toxicol Mech Methods; 2013 Jan; 23(1):48-56. PubMed ID: 22943064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients.
    Taher A; Sheikh-Taha M; Koussa S; Inati A; Neeman R; Mourad F
    Eur J Haematol; 2001 Jul; 67(1):30-4. PubMed ID: 11553264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermediate-term evaluation of a pratical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac t2*.
    Ha SY; Mok AS; Chu WC; Rasalkar DD; Cheuk DK; Chiang AK; Ho MH; Chan GC
    Hemoglobin; 2011; 35(3):199-205. PubMed ID: 21599432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation Modalities.
    Georgiev PG; Sapunarova KG; Goranova-Marinova VS; Goranov SE
    Folia Med (Plovdiv); 2020 Jun; 62(2):265-270. PubMed ID: 32666765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.